Susan R. Hintz, M.D., M.S. Epi.

Robert L. Hess Family Professor and Professor, by courtesy, of Obstetrics and Gynecology

Clinical Focus

Neonatology
Neonatal-Perinatal Medicine

Academic Appointments

Professor - University Medical Line, Pediatrics - Neonatal and Developmental Medicine
Professor - University Medical Line (By courtesy), Obstetrics & Gynecology
Member, Maternal & Child Health Research Institute (MCHRI)

Administrative Appointments

Assistant Professor of Pediatrics, Stanford University School of Medicine (2000 - 2007)
Associate Professor of Pediatrics, Stanford University School of Medicine (2007 - 2012)
Director, Fetal and Pregnancy Health Program, LPCH Stanford (2009 - Present)
Medical Director, California Perinatal Quality Care Collaborative CCS High Risk Infant Follow Up (2010 - Present)
Associate Chief for Prenatal Services, Division of Neonatal and Developmental Medicine, Stanford (2012 - Present)
Professor of Obstetrics and Gynecology (by courtesy), Stanford University School of Medicine (2012 - Present)
Professor of Pediatrics, Stanford University School of Medicine (2012 - Present)

Honors & Awards

Alwin C. Rambar-James B.D. Mark Award for Excellence in Patient Care, Stanford University School of Medicine (2023)
Distinguished Medical Staff Service Award, Lucile Packard Children's Hospital Stanford (2019)
Robert L. Hess Family Endowed Professorship in Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Foundation for Children (2014-present)
Harman Faculty Scholar, MCHRI, The Arline and Pete Faculty Scholar Fund (2009-2015)
Director of Follow Up Programs, Principal Investigator (co-PI 2008-2016), CPQCC-California Children's Services High Risk Infant Follow Up Quality of Care Initiative (2008-present)
Principal Investigator, The SUPPORT NEURO cohort and NEURO School Age Follow Up, NICHD Neonatal Research Network (2008-present)
Principal Investigator, Neurodevelopmental Follow-up, Stanford University site,, NICHD Neonatal Research Network (2001-present)
ROSE award (Recognition of Service Excellence), Lucile Salter Packard Children's Hospital at Stanford (2002, 2006)

Boards, Advisory Committees, Professional Organizations

NEC Society Scientific Advisory Council, NEC Society (2022 - Present)
Member, American Pediatrics Society (2010 - Present)
Fellow, American Academy of Pediatrics (2005 - Present)
Member, Society for Pediatric Research (2003 - Present)
Council, District IX AAP Section on Perinatal Pediatrics, Section on Perinatal Pediatrics, American Academy of Pediatrics (2008 - 2014)
Officer and Membership Secretary, Society for Pediatric Research (2008 - 2014)
APS/SPR Representative, NIH National Child and Maternal Health Education Program Coordinating Committee (2012 - 2016)

Professional Education

Board Certification: American Board of Pediatrics, Neonatal-Perinatal Medicine (2023)
Fellowship: Stanford University School of Medicine (1999) CA
Residency: Stanford University School of Medicine (1996) CA
Chief Resident, Stanford University School of Medicine, Pediatrics (1997)
M.S. Epi, Stanford University, Clinical Epidemiology (2006)
Medical Education: Stanford University School of Medicine (1992) CA
B.S., Stanford University, Biological Sciences (1987)
M.D., Stanford University, Medicine (1992)

Contact

Academic srhintz@stanford.edu Fax: (650) 725-8351

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Neonatology 453 Quarry Rd MC 5660 Stanford CA 94305 Tel: (650) 723-5711 Fax: (650) 723-8351

Additional Clinical Info

Stanford Medicine Children's Health

Current Research and Scholarly Interests

1) Early childhood neurodevelopmental outcomes, mortality and morbidities of extremely premature and high-risk infants
2) Use of advanced neuroimaging and other predictors of neurodevelopmental outcomes in high-risk infants, evidence-based interventions to improve outcomes
3) Quality and process improvement throughout the continuum of care
4) Natural history and outcomes of complex fetal anomalies, implementing innovative fetal therapies.

Clinical Trials

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants Not Recruiting
More
Patent Ductus Arteriosus is a developmental condition commonly observed among preterm infants. It is a condition where the opening between the two major blood vessels leading from the heart fail to close after birth. In the womb, the opening (ductus arteriosus) is the normal part of the circulatory system of the baby, but is expected to close at full term birth. If the opening is tiny, the condition can be self-limiting. If not, medications/surgery are options for treatment. There are two ways to treat patent ductus arteriosus - one is through closure of the opening with an FDA approved device called PICCOLO, the other is through supportive management (medications). No randomized controlled trials have been done previously to see if one of better than the other. Through our PIVOTAL study, the investigators aim to determine is one is indeed better than the other - if it is found that the percutaneous closure with PICCOLO is better, then it would immediately lead to a new standard of care. If not, then the investigators avoid an invasive costly procedure going forward.

Stanford is currently not accepting patients for this trial. For more information, please contact Lynn Peng, MD, .
Lead Sponsor
Stanford Investigators
- Susan R. Hintz, M.D., M.S. Epi.
View full details
Cool Prime Comparative Effectiveness Study for Mild HIE Not Recruiting
More
To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypothermia (TH) in mild HIE on the neonate and his/her family. Determine heterogeneity of the treatment effect across key subgroups obtained in the first 6 hours after birth prior to the decision to initiate therapy.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Krisa Van Meurs
- Susan R. Hintz, M.D., M.S. Epi.
View full details
High-dose Erythropoietin for Asphyxia and Encephalopathy Not Recruiting
More
Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood flow and oxygen to the brain near the time of birth. This results in death or neurologic disabilities including cerebral palsy and cognitive impairment in up to half of affected infants. This clinical trial will determine if the drug erythropoietin (Epo) added to hypothermia (usual therapy) will improve outcomes for infants suffering from HIE.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Courtney Wusthoff, MD
- Susan R. Hintz, M.D., M.S. Epi.
View full details
Follow-up Visit of High Risk Infants Recruiting
More
The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.
Lead Sponsor
Stanford Investigators
- Krisa Van Meurs
- Susan R. Hintz, M.D., M.S. Epi.
View full details
Incubator Weaning of Moderately Preterm Infants Recruiting
More
The objective of this proposal is to evaluate whether weaning from an incubator to a crib at lower versus higher weight, 1600g or 1800g will result in shorter length of hospital stay among moderately preterm infants. The hypothesis of this study is that length of hospital stay (from birth to discharge) will be decreased among moderate preterm infants weaned from an incubator to an open crib at a lower versus higher weight, 1600g vs. 1800g.
Lead Sponsor
Stanford Investigators
- Susan R. Hintz, M.D., M.S. Epi.
View full details
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE) Not Recruiting
More
The Optimizing Cooling trial will compare four whole-body cooling treatments for infants born at 36 weeks gestational age or later with hypoxic-ischemic encephalopathy: (1) cooling for 72 hours to 33.5°C; (2) cooling for 120 hours to 33.5°C; (3) cooling for 72 hours to 32.0°C; and (4) cooling for 120 hours to 32.0°C. The objective of this study is to evaluate whether whole-body cooling initiated at less than 6 hours of age and continued for 120 hours and/or a depth at 32.0°C in will reduce death and disability at 18-22 months corrected age.

Stanford is currently not accepting patients for this trial. For more information, please contact M Bethany Ball, 6507258342.
Lead Sponsor
Stanford Investigators
View full details

2023-24 Courses

Independent Studies
- Directed Reading in Pediatrics
  PEDS 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience
  PEDS 280 (Aut, Win, Spr, Sum)
- Graduate Research
  PEDS 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  PEDS 370 (Aut, Win, Spr, Sum)
- Undergraduate Directed Reading/Research
  PEDS 199 (Aut, Win, Spr, Sum)

Graduate and Fellowship Programs

Epidemiology (Masters Program)

Find a doctor

Clinics & Services

Research Resources

Professional Training

Education Resources

Susan R. Hintz, M.D., M.S. Epi.

Robert L. Hess Family Professor and Professor, by courtesy, of Obstetrics and Gynecology

Stanford Investigators

Stanford Investigators

Stanford Investigators

Stanford Investigators

Stanford Investigators

Stanford Investigators

2023-24 Courses

Graduate and Fellowship Programs